Xtant Medical Holdings, Inc. 8-K

What Happened

• Xtant Medical Holdings, Inc. announced its financial results for the three months ended March 31, 2026 in a press release furnished on Form 8‑K on May 13, 2026. The company reported its quarterly results (earnings/revenue details are provided in the press release attached as Exhibit 99.1).

Key Details

• Filing date: May 13, 2026; quarter covered: three months ended March 31, 2026.
• 2026 Annual Meeting date set for August 7, 2026; exact time and location to be provided in the proxy statement expected to be printed around June 11, 2026 and distributed beginning around June 12, 2026.
• Deadline for stockholder proposals to be included in proxy materials under SEC Rule 14a‑8: proposals must be received by close of business on May 23, 2026.
• Advance notice under the Company’s Bylaws for other stockholder proposals or director nominations (not under Rule 14a‑8) also must be received by close of business on May 23, 2026; universal proxy notice (Rule 14a‑19) deadline for proxy solicitations supporting other director nominees: June 9, 2026.

Why It Matters

• The 8‑K confirms Xtant has released its quarterly results (important for assessing recent revenue and earnings performance); investors should review the attached press release for the specific financial figures and any management commentary.
• Setting the annual meeting date and publishing clear deadlines matters for shareholders who plan to submit proposals or nominate directors — missing these dates can disqualify proposals or preclude inclusion in proxy materials.